Harvest Health & Recreation Inc. (HRVSF) Income Statement Analysis

See more : Wienerberger AG (WBRBF) Income Statement Analysis – Financial Results

Complete financial analysis of Harvest Health & Recreation Inc. (HRVSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Harvest Health & Recreation Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.

You may be interested

Harvest Health & Recreation Inc. (HRVSF)

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Website: http://www.harvesthoc.com

About Harvest Health & Recreation Inc.

Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.

Metric	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue	231.46M	116.78M	77.79K	200.29K	284.45K	482.02K	675.22K	368.83K	292.64K	233.88K	180.62K	147.97K	24.10K
Cost of Revenue	129.87M	73.21M	15.89K	56.47K	31.73K	94.81K	160.79K	51.74K	269.58K	478.39K	372.72K	1.23M	14.92K
Gross Profit	101.59M	43.57M	61.91K	143.82K	252.72K	387.20K	514.43K	317.09K	23.05K	-244.51K	-192.10K	-1.08M	9.18K
Gross Profit Ratio	43.89%	37.31%	79.58%	71.81%	88.84%	80.33%	76.19%	85.97%	7.88%	-104.55%	-106.36%	-728.50%	38.10%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	122.10M	115.86M	83.35K	65.96K	78.32K	129.18K	251.07K	246.79K	446.60K	505.30K	498.98K	498.25K	0.00
Selling & Marketing	4.96M	8.94M	0.00	0.00	0.00	0.00	1.40K	0.00	1.26K	0.00	10.93K	0.00	0.00
SG&A	127.06M	124.80M	83.35K	65.96K	78.32K	129.18K	252.46K	246.79K	447.86K	505.30K	509.91K	498.25K	0.00
Other Expenses	7.92M	10.30M	93.75K	126.55K	300.84K	408.79K	308.00K	180.03K	55.80K	0.00	0.00	0.00	1.46M
Operating Expenses	134.98M	135.10M	177.10K	192.51K	379.15K	537.97K	560.47K	426.82K	503.65K	505.30K	509.91K	498.25K	1.46M
Cost & Expenses	264.85M	208.30M	192.98K	248.98K	410.89K	632.79K	721.26K	478.56K	773.24K	983.69K	882.64K	1.72M	1.48M
Interest Income	444.00K	0.00	0.00	0.00	0.00	0.00	60.03	615.56	568.96	1.21K	1.98K	9.68K	1.53K
Interest Expense	39.06M	16.24M	4.78K	5.50K	3.34K	5.27K	6.99K	10.34K	32.61K	27.68K	16.64K	2.28K	0.00
Depreciation & Amortization	16.67M	12.69M	2.93K	5.22K	3.29K	13.51K	24.44K	6.09K	55.80K	200.11K	165.86K	991.47K	651.57K
EBITDA	-259.00K	-140.80M	-347.62K	-43.47K	-109.40K	-110.67K	-219.74K	-125.25K	-25.86K	-645.52K	-1.56M	-575.04K	-801.24K
EBITDA Ratio	-0.11%	-120.57%	-446.85%	-21.71%	-38.46%	-22.96%	-32.54%	-33.96%	-8.84%	-276.01%	-866.36%	-388.63%	-3,324.16%
Operating Income	-33.39M	-91.52M	-115.19K	-48.69K	-126.44K	-150.77K	-46.04K	-109.73K	-480.60K	-749.81K	-702.02K	-1.58M	-1.45M
Operating Income Ratio	-14.43%	-78.37%	-148.07%	-24.31%	-44.45%	-31.28%	-6.82%	-29.75%	-164.23%	-320.60%	-388.67%	-1,065.22%	-6,033.34%
Total Other Income/Expenses	-21.26M	-80.29M	-240.14K	-5.50K	10.40K	21.32K	-205.13K	-31.96K	366.34K	-97.03K	-933.72K	0.00	0.00
Income Before Tax	-54.65M	-171.81M	-355.33K	-54.19K	-116.04K	-129.45K	-251.17K	-141.69K	-114.26K	-846.84K	-1.64M	0.00	0.00
Income Before Tax Ratio	-23.61%	-147.12%	-456.76%	-27.06%	-40.79%	-26.86%	-37.20%	-38.42%	-39.05%	-362.08%	-905.63%	0.00%	0.00%
Income Tax Expense	3.65M	3.76M	-235.36K	0.00	13.75K	26.59K	-198.14K	-21.61K	398.95K	-69.35K	-917.09K	2.28K	0.00
Net Income	-59.63M	-173.49M	-355.33K	-54.19K	-116.04K	-129.45K	-251.17K	-141.69K	-114.26K	-873.31K	-1.75M	-1.57M	-1.45M
Net Income Ratio	-25.76%	-148.56%	-456.76%	-27.06%	-40.79%	-26.86%	-37.20%	-38.42%	-39.05%	-373.40%	-967.40%	-1,060.22%	-6,027.36%
EPS	-0.17	-0.61	-0.08	-0.01	-0.03	-0.03	-0.06	-0.04	-0.04	-0.42	-1.23	-1.53	-3.86
EPS Diluted	-0.17	-0.61	-0.08	-0.01	-0.03	-0.03	-0.06	-0.04	-0.04	-0.42	-1.23	-1.53	-3.86
Weighted Avg Shares Out	354.76M	286.63M	4.59M	4.00M	4.00M	4.00M	3.95M	3.22M	2.79M	2.09M	1.43M	1.03M	376.52K
Weighted Avg Shares Out (Dil)	354.76M	286.63M	4.59M	4.00M	4.00M	4.00M	3.95M	3.22M	2.79M	2.09M	1.43M	1.03M	376.52K

Notably Quiet Lately, Is This Leading Pot Company Due for a Big Move?

June 3, 2021fool.com

Curaleaf is the top cannabis company in terms of revenue -- but that may not be the case for much longer.

Are Investors Ready For Legal Cannabis? (Podcast Transcript)

June 1, 2021seekingalpha.com

Are Investors Ready For Legal Cannabis? (Podcast Transcript)

What Investors Need to Know About Trulieve's $2.1 Billion Deal to Buy Harvest Health

May 28, 2021fool.com

The latest big marijuana industry buyout looks very attractive based on geography alone.

Verano: Competing With The Biggest MSOs

May 27, 2021seekingalpha.com

Verano: Competing With The Biggest MSOs

Cannabis Dispensary Roundup: Trulieve To Debut In Massachusetts, Harvest Health Opens 10th Pennsylvania Store, Cannabis Jacks Expands In Ontario

May 26, 2021benzinga.com

Cannabis company Trulieve Cannabis Corp. (CSE:TRUL) (OTC:TCNNF) is poised to debut its products in Massachusetts in a Northampton shop. The move follows the company's recent $2.1 billion deal to merge with Harvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HRVSF)

Tenth Harvest-Affiliated Pennsylvania Dispensary Opens in York

May 26, 2021prnewswire.com

PHOENIX, May 26, 2021 /PRNewswire/ -- Harvest Health & Recreation Inc. ("Harvest") (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the opening of a new medical dispensary in York, Pennsylvania. Harvest of York is located at 2300 E Market St, York...

Are Investors Ready For Legal Cannabis? (Podcast)

May 26, 2021seekingalpha.com

Are investors ready for the next leg of cannabis legalization and what it does to cannabis companies. That's a question asked by Mike Regan and Colin Ferrian who run MJResearchCo, which provides rigorous investment analysis of the legal cannabis industry.